09.01.2013 Views

2 - TI Pharma

2 - TI Pharma

2 - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 5 Glucocorticoids, islet-cell function & ANS<br />

SUPPLEMENTARy FIGURES<br />

Supplementary Figure 1. Study Design.<br />

Day<br />

110<br />

-14<br />

S<br />

Baseline<br />

PLB, PRED 7.5 mg or PRED 30 mg QD<br />

-2 -1 1<br />

7<br />

13 14<br />

C M T<br />

V C M<br />

Offtreatment<br />

S: Screening M: Meal Test C: Clamp Test T: start treatment V: Follow-up visits<br />

Supplementary Figure 2A. Combined Hyperinsulinemic-Euglycemic and Hyperglycemic Clamp<br />

Procedure.<br />

Insulin 40 mU/m 2.min<br />

Variable glucose 20% infusion<br />

Plasma Glucose: 5.0 mM 10.0 mM<br />

0 90 120 150 0 10<br />

80 110<br />

M-value -30<br />

Time (min)<br />

Glucose bolus<br />

Supplementary Figure 2B. Double Standardized Meal Challenge Test.<br />

- 60<br />

HRV<br />

studies<br />

Time (min)<br />

5g Arginine<br />

0 60 120 180 240 300 360 420 480<br />

Meal<br />

75 g carbs<br />

50 g fat<br />

34 g protein<br />

Meal<br />

75 g carbs<br />

50 g fat<br />

34 g protein<br />

28<br />

V

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!